We are live on ! Find out more
LFM

Lumina Fund Management Portfolio holdings

AUM $164M
1-Year Est. Return 27.72%
This Fund
S&P 500
This Quarter Est. Return
+4.99%
1 Year Est. Return
+27.72%
3 Year Est. Return
+28.12%
5 Year Est. Return
+101.22%
10 Year Est. Return
+153.06%
AUM
$264M
AUM Growth
+$22.9M
Cap. Flow
+$10.8M
Cap. Flow %
4.08%
Top 10 Hldgs %
94.03%
Holding
33
New
3
Increased
3
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$876K
2
MRK icon
Merck
MRK
+$387K
3
VTRS icon
Viatris
VTRS
+$326K
4
ABCL icon
AbCellera Biologics
ABCL
+$120K
5
ALXN
Alexion Pharmaceuticals
ALXN
+$15.5K

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$4.63M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.75M

Sector Composition

Rank Sector Weight
1 Technology 5.71%
2 Healthcare 4.89%
3 Communication Services 1%
4 Consumer Discretionary 0.53%
5 Financials 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$139M 52.64%
351,001
-12,000
-3% -$4.63M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$76.4M 28.91%
200,000
+40,000
+25% +$15.4M
QQQ icon
3
Invesco QQQ Trust
QQQ
$463B
$14.4M 5.45%
45,100
– –
AAPL icon
4
Apple
AAPL
$4.8T
$7.82M 2.96%
64,000
– –
NXPI icon
5
NXP Semiconductors
NXPI
$67.5B
$2.31M 0.88%
11,500
– –
QCOM icon
6
Qualcomm
QCOM
$180B
$2.03M 0.77%
15,300
– –
CVS icon
7
CVS Health
CVS
$137B
$1.9M 0.72%
25,300
– –
AMGN icon
8
Amgen
AMGN
$197B
$1.62M 0.61%
6,500
– –
TMO icon
9
Thermo Fisher Scientific
TMO
$196B
$1.46M 0.55%
3,200
– –
PARA
10
DELISTED
Paramount Global Class B
PARA
$1.44M 0.54%
31,925
– –
BABA icon
11
Alibaba
BABA
$288B
$1.41M 0.53%
6,200
– –
AVGO icon
12
Broadcom
AVGO
$1.8T
$1.39M 0.53%
30,000
– –
VYM icon
13
Vanguard High Dividend Yield ETF
VYM
$79.7B
$1.39M 0.52%
13,702
– –
PFE icon
14
Pfizer
PFE
$141B
$1.09M 0.41%
30,000
– –
MRK icon
15
Merck
MRK
$307B
$964K 0.36%
13,100
+5,240
+67% +$387K
ILMN icon
16
Illumina
ILMN
$27.9B
$960K 0.36%
2,570
– –
BMY icon
17
Bristol-Myers Squibb
BMY
$123B
$947K 0.36%
15,000
– –
MA icon
18
Mastercard
MA
$484B
$890K 0.34%
2,500
– –
BIIB icon
19
Biogen
BIIB
$29.5B
$867K 0.33%
3,100
– –
REGN icon
20
Regeneron Pharmaceuticals
REGN
$70.5B
$852K 0.32%
+1,800
New +$876K
BIDU icon
21
Baidu
BIDU
$37.4B
$761K 0.29%
3,500
– –
SAIC icon
22
Saic
SAIC
$4.76B
$711K 0.27%
8,500
– –
ALXN
23
DELISTED
Alexion Pharmaceuticals
ALXN
$627K 0.24%
4,100
+100
+3% +$15.5K
EEFT icon
24
Euronet Worldwide
EEFT
$3.1B
$622K 0.24%
4,500
– –
INMD icon
25
InMode
INMD
$883M
$579K 0.22%
16,000
– –
1
2

Similar funds

RWG
Regal Wealth Group Seal Beach, California $162M AUM 19.09% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
ARIS
Advanced Research Investment Solutions Los Angeles, California $160M AUM 5.55% 1-Year Est. Return
RPG
Resource Planning Group Atlanta, Georgia $157M AUM 11.52% 1-Year Est. Return
AMR
Asset Management Resources Hyannis, Massachusetts $176M AUM 15.25% 1-Year Est. Return
DWMG
DB Wealth Management Group San Diego, California $176M AUM 14.41% 1-Year Est. Return
FCPV
FS Capital Partners VI Los Angeles, California $145M AUM 21.54% 1-Year Est. Return
RWA
Rainsberger Wealth Advisors Colorado Springs, Colorado $183M AUM 15.24% 1-Year Est. Return

Lumina Fund Management's Q1 2021 Portfolio in Review

As of Q1 2021, Lumina Fund Management held 33 positions worth $264M, up 9.5% from $241M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Lumina Fund Management deployed $10.8M of net new capital in Q1 2021, opening 3 new positions and adding to 3 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 1,800 shares worth $852K.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, down from 6.5% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $4.63M trimmed.

  • Lumina Fund Management's largest Q1 2021 buy was Regeneron Pharmaceuticals: 1,800 shares worth $852K.
  • Lumina Fund Management added most to Merck in Q1 2021, an estimated $387K increase.
  • Lumina Fund Management's biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.63M.
  • Lumina Fund Management fully exited Alphabet (Google) Class A in Q1 2021, selling an estimated $1.75M.
  • Lumina Fund Management's ten largest holdings make up 94% of its $264M portfolio in Q1 2021.
  • Lumina Fund Management opened 3 new positions and closed 1 in Q1 2021.
  • Lumina Fund Management's portfolio value rose 9.5% quarter-over-quarter to $264M.

Based on Lumina Fund Management's 13F filing for Q1 2021, filed 17 May 2021.